Product Images Asenapine

Asenapine sublingual tablets are available in an original container of 60 tablets, each containing 10 mg of asenapine (as maleate) and inactive ingredients. These tablets are not to be split, cut, crushed, chewed, or swallowed. They are designed for sublingual use only. To use them, place a dry hand under your tongue and allow the tablet to dissolve completely. This medication comes with a black cherry flavor and is produced by SigmaPharm Laboratories, LLC. Read the package insert for dosage information and store at a temperature between 20°-25°C (68°-77°F) with temporary excursions permitted to 15°-30°C (59°-86°F).*

This is a description of a medication with the NDC code 42794-016-22. It contains Asenapine and is available in the form of sublingual tablets. Patients are advised to not split, crush, chew, or swallow the tablet and it should only be dispensed in the original container. The tablets come in Black Cherry flavor and each sublingual tablet contains 5 mg of Asenapine. The usual dosage should be as directed in the package insert. It is recommended to store this medication at a temperature of 20°-25°C (68°-77°F) and excursions up to 15°-30°C (59°-86°F) are permitted. This medication should only be used sublingually, and the tablets should be kept in a dry place. It should be placed under the tongue and allowed to dissolve completely for 10 minutes. Patients should not eat or drink for 10 minutes after administering the tablet.*

Asenapine sublingual tablets are available in an original container of 30 tablets with a strength of 5mg asenapine (as maleate). The tablets are not to be split, crushed, chewed, or swallowed. The tablets have black cherry flavor and are meant for sublingual use only. The recommended dosage should be read from the package insert. The tablets should be stored at 20-25°C (68-77°F) and should not be consumed along with any beverage or food for at least 10 minutes after administration. These tablets are Rx only and should be handled with dry hands. This medication is manufactured by SigmaPharm Laboratories, LLC based in Bensalem, PA.*

NDC 42794-017-22 is a sublingual tablet containing  a certain amount of  mg asenapine. It is very important to read how to take medication since asenapine is the only active element in this medication. It should only be administered sublingually and with dry hands. The dosage information can be found in the package insert. The tablet should not be cut or split and used immediately after being removed from its package. It must be placed whole under the tongue and allowed to dissolve completely. It needs to be stored at a moderate temperature and dispensed only in the original container. Black cherry flavoring has been added to the medication. After adminstering the tablet, the patient should not eat or drink for ten minutes.*

Asenapine is a sublingual tablet medication used to treat certain mental/mood disorders. It should not be split, cut, chewed, or swallowed. Each tablet contains 10 mg of asenapine (as maleate) and inactive ingredients. The usual dosage is indicated in the package insert. The tablet must be stored in a container at a controlled room temperature. The medication is manufactured in Bensalem, PA by Sigmapharm Laboratories, LLC. The label also contains usage instructions, stating that the tablet should be allowed to dissolve completely under the tongue and that the patient should not eat or drink anything for ten minutes after consuming the medication.*

This text appears to be a table of drug interactions and their effects on certain enzymes and pharmacokinetic parameters. It lists various drug inhibitors and inducers of enzymes such as CYP1A2, 2C19, 2D6, and 3A4, as well as UGT1A4. The table also includes the pharmacokinetic parameters Cmax and AUC, and presents fold changes and 90% confidence intervals. Overall, this table provides important information for healthcare professionals when considering drug combinations and their potential effects.*

This text appears to be describing some sort of drug study, where different drugs are being tested as substrates and inhibitors for various enzymes like CYP2D6, CYP1A2, CYP2C19, and CYP3A4. It also mentions parameters like Cmax, AUC, and fold change with 90% CI, which may be used to evaluate the pharmacokinetics (PK) of these drugs. However, the context and purpose of this study cannot be determined without further information.*

This text provides a description of different population categories including levels of renal and hepatic impairment, smoking status, and ethnicity. There are also measurements of pharmacokinetic parameters such as Cmax and AUC, and fold change relative to a reference. The text appears to be a table with specific data points, but without further context, it is unclear what the data represents or how it could be applied.*

This is a medication with NDC number 42794-016-10, designed for sublingual use only. Each tablet contains mg asenapine (as maleate RTAN) along with inactive ingredients. The usual dosage information is available on the package insert, and tablets should not be removed until ready to administer. The tablets should not be crushed, chewed or swallowed, but be placed under the tongue and allowed to dissolve completely. Eating or drinking is not recommended for 10 minutes after administration. The tablets should be stored at 20°-25°C and dispensed only in the original container. The manufacturer is SigmaPharm Laboratories, LLC, located in Bensalem, PA.*